share

Protac Er Degrader-4 CAS NO 2361114-15-8


Unit Price:

CAS No.:2361114-15-8

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Protac Er Degrader-4 is a potent and selective small molecule degrader designed to target the estrogen receptor (ER) for proteasomal degradation via the PROTAC (PROteolysis TArgeting Chimera) mechanism. This compound matters as a critical research tool for investigating novel therapeutic strategies in oncology, particularly for hormone receptor-positive cancers. It is primarily needed by pharmaceutical R&D teams, academic researchers, and biotechnology companies focused on targeted protein degradation, cancer biology, and drug discovery.

Application

  • Targeted Protein Degradation Research: A key chemical probe for studying PROTAC-mediated degradation of the estrogen receptor (ERα/ERβ) in cellular and biochemical assays.
  • Oncology Drug Discovery: Used in preclinical research to validate the ER as a therapeutic target and to explore degradation as an alternative to traditional receptor antagonism for breast and other hormone-dependent cancers.
  • Mechanism of Action Studies: Facilitates the investigation of ubiquitin-proteasome system (UPS) engagement, ternary complex formation, and kinetics of protein knockdown.
  • Biomarker and Resistance Research: Employed to model and understand potential resistance mechanisms to protein degraders in cancer cell lines.
  • High-Throughput Screening (HTS): Serves as a reference compound or positive control in screening campaigns for novel ER degraders or E3 ligase recruiters.
  • Chemical Biology Tool: Used to elucidate the downstream signaling pathways and phenotypic consequences of acute ER loss in various biological models.

Basic Information

Product Name Protac Er Degrader-4
CAS No. 2361114-15-8
Molecular Formula Contact for details
Molecular Weight Contact for details
Synonyms PROTAC ER Degrader-4; ER Degrader-4; PROTAC Estrogen Receptor Degrader 4; ARV-471 analogue; Estrogen Receptor PROTAC; ER-targeting PROTAC; Proteolysis Targeting Chimera for ER; Estrogen receptor alpha degrader
EINECS Contact for details

Quality Control

Our Protac Er Degrader-4 is manufactured under strict quality management systems to ensure batch-to-batch consistency and reliability for critical research applications. Each lot undergoes comprehensive analytical characterization, including purity verification by HPLC and structural confirmation. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting identity, purity, and other relevant specifications.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below under an inert atmosphere. The product is hygroscopic (moisture-sensitive); allow the vial to equilibrate to room temperature in a desiccator before opening to minimize exposure to moisture.

Specification

Item Specification
Appearance White to off-white solid
Identification (HPLC) Conforms
Purity (HPLC) ≥95%
Water Content (KF) ≤1.0%
Solubility Soluble in DMSO, DMF; sparingly soluble in aqueous buffers

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.